NEU 0.55% $19.86 neuren pharmaceuticals limited

Ann: Prader-Willi syndrome IND for NNZ-2591 approved by FDA, page-5

  1. 5,867 Posts.
    lightbulb Created with Sketch. 17380
    Neuren previously reported positive results in the Magel-2 mouse model of Prader-Willi syndrome, in which treatment with NNZ-2591 for 6 weeks normalized fat mass, insulin levels, IGF1 levels and all behavioural deficits.

    And this is why I expect this particular trial to be keenly watched...
 
watchlist Created with Sketch. Add NEU (ASX) to my watchlist
(20min delay)
Last
$19.86
Change
-0.110(0.55%)
Mkt cap ! $2.523B
Open High Low Value Volume
$19.96 $19.96 $19.69 $3.371M 170.3K

Buyers (Bids)

No. Vol. Price($)
12 415 $19.86
 

Sellers (Offers)

Price($) Vol. No.
$19.87 400 8
View Market Depth
Last trade - 15.48pm 05/07/2024 (20 minute delay) ?
NEU (ASX) Chart
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.